Humanistic outcomes and patient acceptance of the pharmacist-led medication review "Polymedication Check" in primary care in Switzerland: a prospective randomized controlled trial
- PMID: 29950820
- PMCID: PMC6016257
- DOI: 10.2147/PPA.S160789
Humanistic outcomes and patient acceptance of the pharmacist-led medication review "Polymedication Check" in primary care in Switzerland: a prospective randomized controlled trial
Abstract
Background: Since 2010, Swiss pharmacists have been offering their patients a Polymedication Check (PMC), a new cognitive pharmacy service in the form of a medication review for patients taking ≥4 prescribed medicines for a period >3 months. While a first publication of this project reported on the impact of the PMC on patients' adherence, the present paper focuses on humanistic outcomes.
Methods: This randomized controlled trial was conducted in 54 Swiss community pharmacies. After recruitment, the intervention group underwent a PMC in the pharmacy (T-0) and 28 weeks after T-0 (T-28), while the control group did not receive the PMC until 28 weeks after the study started (T-28). A clinical psychologist, blinded to the intervention, interviewed the patients 2 weeks (T-2) and 16 weeks (T-16) after T-0. Interviewer and patient both rated patient's knowledge of own medicines use. Furthermore, patients reported satisfaction with their pharmacy and appraisal of their medicines use. The availability of a written medication plan was assessed at T-16. Acceptance of the service was measured using a patient's self-report questionnaire at T-28.
Results: General linear model analysis for knowledge about medicines revealed a significant effect on the factor "group" (P=5.86, p=0.016), indicating that the intervention group had higher ratings for knowledge about their medication at T-2 and T-16 compared to controls. The majority (83%) of patients judged the counseling by the pharmacist as being helpful for their daily medication management. Availability of a written medication plan was comparable in both groups (52.5% vs 52.7%, p>0.05).
Conclusion: For the first time, the benefits of a complex pharmacist-led intervention were evaluated in Swiss primary care with a randomized controlled trial. The PMC increased patients' subjective knowledge of their medicines compared to no medication review. The effect remained sustainable over time. Recommendations resulting from the pharmacist-led service were highly appreciated by the patients.
Keywords: community pharmacy; humanistic outcomes; medication review; patient acceptance; patient knowledge; pharmaceutical care; polypharmacy.
Conflict of interest statement
Disclosure The authors report no other conflicts of interest in this work.
Figures
Similar articles
-
Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy--a prospective randomised controlled trial.BMC Health Serv Res. 2016 Apr 23;16:145. doi: 10.1186/s12913-016-1384-8. BMC Health Serv Res. 2016. PMID: 27108410 Free PMC article. Clinical Trial.
-
Evaluation of a Collaborative Protocolized Approach by Community Pharmacists and General Medical Practitioners for an Australian Minor Ailments Scheme: Protocol for a Cluster Randomized Controlled Trial.JMIR Res Protoc. 2019 Aug 9;8(8):e13973. doi: 10.2196/13973. JMIR Res Protoc. 2019. PMID: 31400107 Free PMC article.
-
The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence.BMJ Qual Saf. 2016 Oct;25(10):759-69. doi: 10.1136/bmjqs-2015-004670. Epub 2016 Jan 11. BMJ Qual Saf. 2016. PMID: 26755665 Clinical Trial.
-
Cluster randomised controlled trial evaluating the clinical and humanistic impact of a pharmacist-led minor ailment service.BMJ Qual Saf. 2020 Nov;29(11):921-931. doi: 10.1136/bmjqs-2019-010608. Epub 2020 Mar 5. BMJ Qual Saf. 2020. PMID: 32139400 Clinical Trial.
-
Development of Clinical Pharmacy in Switzerland: Involvement of Community Pharmacists in Care for Older Patients.Drugs Aging. 2016 Mar;33(3):205-11. doi: 10.1007/s40266-016-0353-6. Drugs Aging. 2016. PMID: 26884391 Review.
Cited by
-
Improved adherence with Medicines Use Review service in Slovenia: a randomized controlled trial.BMC Health Serv Res. 2021 Mar 22;21(1):266. doi: 10.1186/s12913-021-06223-8. BMC Health Serv Res. 2021. PMID: 33752647 Free PMC article. Clinical Trial.
-
Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies.Pharmacy (Basel). 2020 Mar 28;8(2):54. doi: 10.3390/pharmacy8020054. Pharmacy (Basel). 2020. PMID: 32231095 Free PMC article.
-
For which patient subgroups are there positive outcomes from a medication review? A systematic review.Pharm Pract (Granada). 2020 Oct-Dec;18(4):1976. doi: 10.18549/PharmPract.2020.4.1976. Epub 2020 Oct 27. Pharm Pract (Granada). 2020. PMID: 33224322 Free PMC article.
-
'He or she maybe doesn't know there is such a thing as a review': A qualitative investigation exploring barriers and facilitators to accessing medication reviews from the perspective of people from ethnic minority communities.Health Expect. 2022 Aug;25(4):1432-1443. doi: 10.1111/hex.13482. Epub 2022 Apr 5. Health Expect. 2022. PMID: 35384182 Free PMC article.
-
Evaluation of an enhanced service for medication review with follow up in Swiss community pharmacies: Pre-post study protocol.PLoS One. 2023 Oct 17;18(10):e0292037. doi: 10.1371/journal.pone.0292037. eCollection 2023. PLoS One. 2023. PMID: 37847695 Free PMC article.
References
-
- Hersberger KE, Messerli M. Development of clinical pharmacy in Switzerland: involvement of community pharmacists in care for older patients. Drugs Aging. 2016;33(3):205–211. - PubMed
-
- Eichenberger PM, Lampert ML, Kahmann IV, van Mil JW, Hersberger KE. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci. 2010;32(3):362–372. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical